BackJasper Therapeutics Overview

Jasper Therapeutics Long Term Debt

Jasper Therapeutics's long-term debt is $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-755000.00 vs prior year quarter

Peer average

Loading

Jasper Therapeutics Long Term Debt History

Loading

Jasper Therapeutics vs. peers: Long Term Debt Comparison

Loading

Jasper Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Jasper Therapeutics (JSPR) FAQ

Jasper Therapeutics (JSPR) currently reports a long-term debt of $0 as of March 2026. That compares with $760K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Jasper Therapeutics's long-term debt history and peer comparisons.

Jasper Therapeutics's long-term debt decreased from $760K to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jasper Therapeutics reported $0 in long-term debt as of March 2026. That compares with $760K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Jasper Therapeutics, and consider following JSPR for alerts when major investors trade the stock.